查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1601274

去腎神經設備市場：按技術、產品、疾病應用和最終用戶分類 - 全球預測 2025-2030

Renal Denervation Devices Market by Technology (Micro-Infusion-Based, Pharmacologic Ablation, Radiofrequency-Based), Products (Catheters, Nerve Modifying Agents, RF Generator), Disease Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年去腎神經裝置市值為2.3629億美元，預計到2024年將達到2.6644億美元，複合年成長率為13.68%，預計到2030年將達到5.7985億美元。

去腎神經裝置是一種透過抑制腎動脈神經活動來治療高血壓的醫療設備，在調節血壓方面發揮重要作用。這種需求是由於抗治療性高血壓的盛行率不斷增加而產生的，即患者對傳統藥物治療沒有反應。這些設備的主要用途是降低尚未透過藥物手段緩解的高血壓患者的血壓，從而可能降低中風、心臟病和腎衰竭的風險。最終用途通常是在醫療機構內，特別是介入心臟科。根據市場洞察，高血壓病例的增加和老年人口的增加、微創手術技術的技術進步正在推動市場的強勁成長軌跡。最新的機會在於人工智慧和機器學習的整合，以提高設備的有效性和患者的客製化。醫療科技公司和醫療保健組織之間的合作也提供了一條前進的道路。然而，市場成長面臨著高昂的初始成本、嚴格的監管核准以及臨床試驗結果喜憂參半的挑戰，這些結果有時令人懷疑療效。這是由於缺乏患者意識和缺乏訓練有素的專家來進行干預。具有高業務成長潛力的創新領域包括開拓具有改進安全性的下一代設備、在高血壓發病率迅速上升的新興市場擴大使用，以及用於遠端監測和病人參與的數位化例子包括健康技術的使用。透過先進的資料分析來了解患者的人口統計和行為也可以提高競爭力。總體而言，去腎神經支配市場的競爭是溫和的，現有參與者和利基公司專注於創新以獲得市場佔有率。鼓勵公司投資實證研究，以增強臨床結果和市場可信度。

主要市場統計
基準年[2023] 2.3629億美元
預測年份 [2024] 26644萬美元
預測年份 [2030] 57985萬美元
複合年成長率（%） 13.68%

市場動態：快速發展的去腎神經設備市場的關鍵市場洞察

供需的動態交互作用正在改變腎去神經裝置市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 隨著年齡的成長，鬱血性慢性腎衰竭的盛行率不斷增加
    • 微創手術的介紹及發展趨勢
  • 市場限制因素
    • 與去腎神經裝置相關的高成本
  • 市場機會
    • 腎臟去神經裝置的技術進步與改進
    • 繼續出版腎去神經術臨床指引和增加臨床評估研究數量
  • 市場挑戰
    • 政府對產品核可法規嚴格且缺乏經驗豐富的醫療保健專業人員

波特五力：駕馭去腎臟神經設備市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解去腎神經設備市場的外部影響

外部宏觀環境因素在塑造去腎神經裝置市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解去腎神經裝置市場的競爭格局

對腎去神經設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣去腎神經裝置市場供應商的績效評估

FPNV 定位矩陣是評估腎臟去神經設備市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 隨著人口老化，慢性腎衰竭的盛行率不斷增加
      • 微創手術的日益普及與趨勢
    • 抑制因素
      • 與去腎神經裝置相關的高成本
    • 機會
      • 腎臟去神經裝置的技術進步與改進
      • 腎去神經術臨床指引的持續出版和臨床評估研究的數量不斷增加
    • 任務
      • 關於產品核可的嚴格政府法規和缺乏經驗豐富的醫療保健專業人員
  • 市場區隔分析
    • 技術：超音波腎超音波切除技術採用率高
    • 產品：積極使用多電極導管，縮短治療時間
    • 疾病應用：去腎神經裝置在高血壓治療的使用增加
    • 最終用戶：門診護理中心偏好去腎神經裝置作為微創且經濟高效的解決方案
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章去腎臟神經設備市場：依技術分類

  • 微輸液底座
  • 藥物消融
  • 射頻基地
  • 超音波基地

第7章腎臟去神經設備市場：依產品

  • 導管
    • 多電極導管
    • 單電極導管
  • 神經調節劑
  • 射頻發生器

第8章去腎神經裝置市場依疾病分類的應用

  • 糖尿病
  • 心臟衰竭
  • 高血壓
  • 腎衰竭

第9章去腎神經裝置市場：依最終用戶分類

  • 門診治療中心
  • 診斷中心和醫院
  • 研究和學術

第10章美洲去腎神經裝置市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太去腎臟神經設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲去腎神經裝置市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Record Medical 和 Otsuka Medical Devices 宣布首款 FDA核准的去腎神經系統用於治療高血壓
    • FDA核准Verve Medical 的 IDE 腎盂去神經術研究
    • 韓國Start-UpsKalos 獲得 350 萬美元津貼，用於開發治療高血壓的去腎神經裝置
    • 德國正在進行超音波消融腎去超音波抗治療性高血壓的早期療效評估
    • Andera Partners 投資了一家醫療技術公司 SoniVie，該公司正在開發一種有前途的治療高血壓的設備
    • 法國Medtronic公司生產的腎臟去神經導管 SYMPLICITY SPYRAL 過渡蓋
    • 上海金葉醫療科技有限公司獲數百萬人民幣C輪融資
    • SPYRAL HTN-ON MED 試驗證明了有意義的臨床益處，與其他 SPYRAL HTN 腎臟去神經試驗一致
    • Sonivee 獲得 FDA 的 IDE核准，用於使用腎動脈去神經 TIVUS 技術治療高血壓的先驅性研究
    • Ablative Solutions 在 D 輪資金籌措中籌集了 9,140 萬美元
    • Clinical Accelerator 宣布與 Verve Medical 合作進行抗治療性的早期人體可行性研究

公司名單

  • Abbott Laboratories
  • Ablative Solutions, Inc.
  • AngioDynamics, Inc.
  • Aria CV, Inc.
  • AtriCure, Inc.
  • Bio-Heart
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Kalos Medical
  • Medtronic PLC
  • Mercator MedSystems, Inc.
  • Otsuka Holdings Co., Ltd.
  • Shanghai Meiliweiye Medical Technology Co., Ltd.
  • SoniVie
  • Symap Medical, Ltd.
  • Symple Surgical, Inc.
  • Terumo Corporation
Product Code: MRR-957C47F91FC5

The Renal Denervation Devices Market was valued at USD 236.29 million in 2023, expected to reach USD 266.44 million in 2024, and is projected to grow at a CAGR of 13.68%, to USD 579.85 million by 2030.

Renal denervation devices are medical tools used to treat hypertension by disrupting nerve activity in the renal arteries, which play a crucial role in blood pressure regulation. Their necessity arises from the increasing prevalence of treatment-resistant hypertension, a condition where patients fail to respond to traditional medications. The primary application of these devices is in reducing blood pressure among hypertensive patients who have not found relief through pharmacological means, potentially lowering the risks of stroke, heart attack, and kidney failure. End-use is typically within healthcare facilities, specifically interventional cardiology departments. Market insights reveal a robust growth trajectory fueled by rising hypertension cases and a growing geriatric population, coupled with technological advancements in minimally invasive surgical techniques. The latest opportunities lie in the integration of AI and machine learning to enhance device efficacy and patient customization. Collaborations between medical technology companies and healthcare institutions also offer pathways for advancements. However, market growth is challenged by high initial costs, stringent regulatory approvals, and the mixed results from clinical trials that occasionally question efficacy. In this context, limitations involve a lack of awareness among patients and a deficiency in skilled personnel trained to perform the interventions. Innovative areas with high potential for business growth include the development of next-generation devices with improved safety profiles, expanding use in emerging markets where hypertension rates are skyrocketing, and leveraging digital health technologies for remote monitoring and patient engagement. Understanding patient demographics and behavior through advanced data analytics can also provide a competitive edge. Overall, the renal denervation market is moderately competitive, with a blend of established players and niche companies focusing on innovation to claim market share. Companies are advised to invest in evidence-based research to strengthen clinical outcomes and market credibility.

KEY MARKET STATISTICS
Base Year [2023] USD 236.29 million
Estimated Year [2024] USD 266.44 million
Forecast Year [2030] USD 579.85 million
CAGR (%) 13.68%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Renal Denervation Devices Market

The Renal Denervation Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of congestive chronic renal failure with aging population
    • Growing adoption and inclination towards minimally invasive surgical procedures
  • Market Restraints
    • High cost associated with renal denervation devices
  • Market Opportunities
    • Technological advancements and improvements in renal denervation devices
    • Ongoing publishing of clinical guidelines for renal denervation and increasing clinical assessment studies
  • Market Challenges
    • Strict government regulations for product approval coupled with lack of experienced healthcare professionals

Porter's Five Forces: A Strategic Tool for Navigating the Renal Denervation Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Renal Denervation Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Renal Denervation Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Renal Denervation Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Renal Denervation Devices Market

A detailed market share analysis in the Renal Denervation Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Renal Denervation Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Renal Denervation Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Renal Denervation Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Ablative Solutions, Inc., AngioDynamics, Inc., Aria CV, Inc., AtriCure, Inc., Bio-Heart, Boston Scientific Corporation, Cardinal Health, Inc., Kalos Medical, Medtronic PLC, Mercator MedSystems, Inc., Otsuka Holdings Co., Ltd., Shanghai Meiliweiye Medical Technology Co., Ltd., SoniVie, Symap Medical, Ltd., Symple Surgical, Inc., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Renal Denervation Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Micro-Infusion-Based, Pharmacologic Ablation, Radiofrequency-Based, and Ultrasound-Based.
  • Based on Products, market is studied across Catheters, Nerve Modifying Agents, and RF Generator. The Catheters is further studied across Multi Electrode Catheter and Single Electrode Catheter.
  • Based on Disease Application, market is studied across Diabetes, Heart Failure, Hypertension, and Renal Failure.
  • Based on End-User, market is studied across Ambulatory Care Centers, Diagnostic Centers & Hospitals, and Research & Academia.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of congestive chronic renal failure with aging population
      • 5.1.1.2. Growing adoption and inclination towards minimally invasive surgical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with renal denervation devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements and improvements in renal denervation devices
      • 5.1.3.2. Ongoing publishing of clinical guidelines for renal denervation and increasing clinical assessment studies
    • 5.1.4. Challenges
      • 5.1.4.1. Strict government regulations for product approval coupled with lack of experienced healthcare professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: High adoption of ultrasound-based renal denervation technology
    • 5.2.2. Product: Significant use of multi-electrode catheters for their shorter-time of procedures
    • 5.2.3. Disease Application: Proliferating use of renal denervation devices for treating hypertension
    • 5.2.4. End-User: Ambulatory care centers prioritize renal denervation devices as a minimally invasive and cost-effective solution
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Renal Denervation Devices Market, by Technology

  • 6.1. Introduction
  • 6.2. Micro-Infusion-Based
  • 6.3. Pharmacologic Ablation
  • 6.4. Radiofrequency-Based
  • 6.5. Ultrasound-Based

7. Renal Denervation Devices Market, by Products

  • 7.1. Introduction
  • 7.2. Catheters
    • 7.2.1. Multi Electrode Catheter
    • 7.2.2. Single Electrode Catheter
  • 7.3. Nerve Modifying Agents
  • 7.4. RF Generator

8. Renal Denervation Devices Market, by Disease Application

  • 8.1. Introduction
  • 8.2. Diabetes
  • 8.3. Heart Failure
  • 8.4. Hypertension
  • 8.5. Renal Failure

9. Renal Denervation Devices Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Care Centers
  • 9.3. Diagnostic Centers & Hospitals
  • 9.4. Research & Academia

10. Americas Renal Denervation Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Renal Denervation Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Renal Denervation Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension
    • 13.3.2. FDA Approves Verve Medical's IDE Renal Pelvic Denervation Trial
    • 13.3.3. Korean Startup Kalos Gets USD 3.5 Million Grant to Develop Renal Denervation Device for hypertension Treatment
    • 13.3.4. Renal Denervation Using Ultrasound Ablation in Treatment-Resistant Hypertension is Being Evaluated for Early Benefit Assessment in Germany
    • 13.3.5. Andera Partners Invests in SoniVie, a Medtech Company Developing a Promising Device for the Treatment of Hypertension
    • 13.3.6. Transitional Coverage for Renal Denervation Catheter SYMPLICITY SPYRAL from Medtronic in France
    • 13.3.7. Shanghai Golden Leaf Med Tec Co., Ltd Secures Hundreds of Mns of CNY in Series C Round
    • 13.3.8. SPYRAL HTN-ON MED Study Demonstrates Meaningful Clinical Benefits Consistent with other SPYRAL HTN Renal Denervation Trials
    • 13.3.9. SoniVie Receives IDE Approval from FDA for its Pilot Study to Treat Hypertension with its Renal Artery Denervation TIVUS Technology
    • 13.3.10. Ablative Solutions Raises USD 91.4 Million in Series D Financing Round
    • 13.3.11. Clinical Accelerator Announces Collaboration with Verve Medical to Conduct an Early Human Feasibility Study for Treatment-Resistant Hypertension

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Ablative Solutions, Inc.
  • 3. AngioDynamics, Inc.
  • 4. Aria CV, Inc.
  • 5. AtriCure, Inc.
  • 6. Bio-Heart
  • 7. Boston Scientific Corporation
  • 8. Cardinal Health, Inc.
  • 9. Kalos Medical
  • 10. Medtronic PLC
  • 11. Mercator MedSystems, Inc.
  • 12. Otsuka Holdings Co., Ltd.
  • 13. Shanghai Meiliweiye Medical Technology Co., Ltd.
  • 14. SoniVie
  • 15. Symap Medical, Ltd.
  • 16. Symple Surgical, Inc.
  • 17. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. RENAL DENERVATION DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. RENAL DENERVATION DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, 2018-2030 (USD THOUSAND)
  • FIGURE 4. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 5. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 6. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 8. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 10. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 12. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 14. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 16. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 18. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 22. RENAL DENERVATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. RENAL DENERVATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RENAL DENERVATION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, 2018-2030 (USD THOUSAND)
  • TABLE 4. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 5. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 6. RENAL DENERVATION DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 8. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY MICRO-INFUSION-BASED, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 9. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PHARMACOLOGIC ABLATION, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 10. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RADIOFREQUENCY-BASED, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 11. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY ULTRASOUND-BASED, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 12. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 13. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 14. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY MULTI ELECTRODE CATHETER, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 15. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY SINGLE ELECTRODE CATHETER, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 16. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 17. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY NERVE MODIFYING AGENTS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 18. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RF GENERATOR, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 19. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 20. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 21. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 22. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 23. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RENAL FAILURE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 24. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 25. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 26. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & HOSPITALS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 27. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RESEARCH & ACADEMIA, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 28. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 29. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 30. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 31. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 32. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 33. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 34. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 35. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 36. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 37. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 38. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 39. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 40. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 41. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 42. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 43. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 44. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 45. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 46. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 47. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 48. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 49. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 50. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 51. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 52. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 53. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 54. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 55. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 56. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 57. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 58. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 59. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
  • TABLE 60. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 61. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 62. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 63. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 64. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 65. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 66. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 67. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 68. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 69. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 70. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 71. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 72. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 73. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 74. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 75. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 76. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 77. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 78. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 79. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 80. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 81. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 82. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 83. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 84. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 85. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 86. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 87. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 88. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 89. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 90. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 91. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 92. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 93. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 94. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 95. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 96. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 97. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 98. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 99. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 100. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 101. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 102. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 103. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 104. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 105. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 106. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 107. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 108. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 109. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 110. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 111. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 112. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 113. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 114. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 115. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 116. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 117. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 118. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 119. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 120. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 121. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 122. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 123. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 124. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 125. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 132. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 133. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 134. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 135. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 136. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 137. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 138. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 139. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 140. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 141. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 142. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 143. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 144. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 145. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 146. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 147. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 148. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 149. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 150. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 151. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 152. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 153. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 154. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 155. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 156. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 157. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 158. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 159. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 160. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 161. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 162. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 163. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 164. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 165. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 166. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 167. NETHERLANDS RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 168. NETHERLANDS RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 169. NETHERLANDS RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 170. NETHERLANDS RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 171. NETHERLANDS RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 172. NIGERIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 173. NIGERIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 174. NIGERIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 175. NIGERIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 176. NIGERIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 177. NORWAY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 178. NORWAY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 179. NORWAY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 180. NORWAY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 181. NORWAY RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 182. POLAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 183. POLAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 184. POLAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 185. POLAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 186. POLAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 187. QATAR RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 188. QATAR RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 189. QATAR RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 190. QATAR RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 191. QATAR RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 192. RUSSIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 193. RUSSIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 194. RUSSIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 195. RUSSIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 196. RUSSIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 197. SAUDI ARABIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 198. SAUDI ARABIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 199. SAUDI ARABIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 200. SAUDI ARABIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 201. SAUDI ARABIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 202. SOUTH AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 203. SOUTH AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 204. SOUTH AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 205. SOUTH AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 206. SOUTH AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 207. SPAIN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 208. SPAIN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 209. SPAIN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 210. SPAIN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 211. SPAIN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 212. SWEDEN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 213. SWEDEN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 214. SWEDEN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 215. SWEDEN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 216. SWEDEN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 217. SWITZERLAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 218. SWITZERLAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 219. SWITZERLAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 220. SWITZERLAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 221. SWITZERLAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 222. TURKEY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 223. TURKEY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 224. TURKEY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 225. TURKEY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 226. TURKEY RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 227. UNITED ARAB EMIRATES RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 228. UNITED ARAB EMIRATES RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 229. UNITED ARAB EMIRATES RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 230. UNITED ARAB EMIRATES RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 231. UNITED ARAB EMIRATES RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 232. UNITED KINGDOM RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 233. UNITED KINGDOM RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 234. UNITED KINGDOM RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 235. UNITED KINGDOM RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 236. UNITED KINGDOM RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 237. RENAL DENERVATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. RENAL DENERVATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023